NEW Report - Tribal Law & Policy: Alzheimer's Disease and Related

Por um escritor misterioso

Descrição

IA2 and Splaine Consulting have created policy report for American Indian and Alaska Native Alzheimer's Disease and Related Dementia Issues
NEW Report - Tribal Law & Policy: Alzheimer's Disease and Related
Chronic Diseases and Dementia
NEW Report - Tribal Law & Policy: Alzheimer's Disease and Related
How Race and Ethnicity Impact Alzheimer's Disease Care
NEW Report - Tribal Law & Policy: Alzheimer's Disease and Related
BioVie reports protocol deviations in Phase III Alzheimer's trial - Clinical Trials Arena
NEW Report - Tribal Law & Policy: Alzheimer's Disease and Related
Allergan Acquires Chase Pharmaceuticals to Expand CNS R&D Pipeline and Build on Commitment to Alzheimer's Disease
NEW Report - Tribal Law & Policy: Alzheimer's Disease and Related
Exploring the Multitarget Activity of Wedelolactone against Alzheimer's Disease: Insights from In Silico Study
NEW Report - Tribal Law & Policy: Alzheimer's Disease and Related
Allergan and Adamas Announce New Expanded Indication for NAMZARIC® (Memantine and Donepezil Hydrochlorides) Extended Release for the Treatment of Moderate to Severe Alzheimer's Disease
NEW Report - Tribal Law & Policy: Alzheimer's Disease and Related
Therapeutic Targeting of Repurposed Anticancer Drugs in Alzheimer's Disease: Using the Multiomics Approach
NEW Report - Tribal Law & Policy: Alzheimer's Disease and Related
Resource - Dementia Risk Reduction Flyers - International Association for Indigenous Aging
NEW Report - Tribal Law & Policy: Alzheimer's Disease and Related
New Medicare analysis study reveals critical gaps and disparities in access to Parkinson's disease care
de por adulto (o preço varia de acordo com o tamanho do grupo)